Monoclonal antibody treatment readily available for early COVID-19 at Stanford Health Care | News Center
“More than a 12 months into this pandemic, we have some really successful vaccines,” Singh explained. “But we haven’t seen related developments in treatment of moderate to moderate COVID-19. Now we at last have a little something to provide higher-possibility sufferers. These monoclonal antibodies neutralize the virus really effectively.” In November, the Food and Drug […]
Continue Reading